BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 11602545)

  • 21. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
    Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
    Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Am Heart J; 2000 Dec; 140(6):878-85. PubMed ID: 11099991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction.
    Stamboul K; Fauchier L; Gudjoncik A; Buffet P; Garnier F; Lorgis L; Beer JC; Touzery C; Cottin Y
    Arch Cardiovasc Dis; 2015 Nov; 108(11):598-605. PubMed ID: 26525569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.
    Rathore SS; Berger AK; Weinfurt KP; Schulman KA; Oetgen WJ; Gersh BJ; Solomon AJ
    Circulation; 2000 Mar; 101(9):969-74. PubMed ID: 10704162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.
    Ruddox V; Sandven I; Munkhaugen J; Skattebu J; Edvardsen T; Otterstad JE
    Eur J Prev Cardiol; 2017 Sep; 24(14):1555-1566. PubMed ID: 28617620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Crenshaw BS; Ward SR; Granger CB; Stebbins AL; Topol EJ; Califf RM
    J Am Coll Cardiol; 1997 Aug; 30(2):406-13. PubMed ID: 9247512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Supraventricular tachyarrhythmias during acute myocardial infarction: short- and mid-term clinical significance, therapy and prevention of relapse].
    Berisso MZ; Ferroni A; Molini D; Vecchio C
    G Ital Cardiol; 1991 Jan; 21(1):49-58. PubMed ID: 2055377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of different types of atrial fibrillation in the primary angioplasty era.
    Viliani D; Vivas D; Chung M; Pérez-Vizcayno MJ; Hernández-Antolín R; Bañuelos C; Escaned J; Fernández-Ortiz A; Jiménez-Quevedo P; Vilacosta I; Macaya C; Alfonso F
    Coron Artery Dis; 2012 Dec; 23(8):511-6. PubMed ID: 22990415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
    Ambrosioni E; Borghi C; Magnani B
    N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group.
    Tanne D; Goldbourt U; Zion M; Reicher-Reiss H; Kaplinsky E; Behar S
    Stroke; 1993 Oct; 24(10):1490-5. PubMed ID: 8378952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction.
    Mont L; Cinca J; Blanch P; Blanco J; Figueras J; Brotons C; Soler-Soler J
    J Am Coll Cardiol; 1996 Dec; 28(7):1670-6. PubMed ID: 8962550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
    Goa KL; Balfour JA; Zuanetti G
    Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM;
    Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V.
    Askari AT; Shishehbor MH; Kaminski MA; Riley MJ; Hsu A; Lincoff AM;
    Am Heart J; 2009 Aug; 158(2):238-43. PubMed ID: 19619700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Anti-inflammatory Therapy Prevent Atrial Fibrillation in Myocardial Infarction Patients?
    Nakayama Y; Fujiu K
    Int Heart J; 2018; 59(1):3-5. PubMed ID: 29375115
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
    Ball SG; Hall AS
    Am Heart J; 1996 Jul; 132(1 Pt 2 Su):244-50. PubMed ID: 8677863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective.
    Goldberg RJ; Yarzebski J; Lessard D; Wu J; Gore JM
    Am Heart J; 2002 Mar; 143(3):519-27. PubMed ID: 11868060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.